DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Status of Application
Claims 1-20 are pending and presented for examination.
Response to Arguments
Applicant’s arguments with respect to claim(s) 1-20 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument.
Claim Interpretation
Claims 1-6 are directed to an inhibitor comprising a compound of Formula 1 and then recites how the inhibitor is adsorbed on substrates, the types of substrates and the adsorption energy on the substrates. However, the claims are only directed towards an inhibitor (not a system including the inhibitor and other components) and the manner in which it is used or the substrates it is applied on does not change the actual inhibitor itself. Therefore, any prior art which teaches a compound having the formula as claimed meets the limitations of the claimed inhibitor regardless of what substrates or process the compound is used in.
Claim Rejections - 35 USC § 112(a)
The following is a quotation of the first paragraph of 35 U.S.C. 112(a):
(a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention.
The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112:
The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention.
1. Claim 20 is rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Claim 20 newly recites a thickness “greater than a thickness of any subsequently deposited material formed above the surface of the first layer”. This is not supported by the original disclosure. Rather, the original disclosure only supports a thickness in the range of from about 1.5 to about 5 and does not support that it relates to any subsequently deposited material. The original disclosure fails to provide support for the newly added limitations; therefore, claim 20 fails to comply with the written description requirement.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
2. Claim(s) 1-6 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Braden et al. (U.S. Pat. No. 4420433).
Regarding claims 1-6, Braden teaches a compound, 3-trifluoromethyl benzaldehyde (column 6, lines 51-61), which meets the limitations of the formula and is one of the compounds in the Markush group of claim 3. Additionally, as this is one of the compounds recited in claim 3 it inherently can act as an inhibitor and can be used in the intended use of application to substrates as claimed and can be provided on a substrate to yield an adsorption energy as claimed. Braden teaches an inhibitor as required by claims 1-6; therefore, Braden anticipates the claims.
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows:
1. Determining the scope and contents of the prior art.
2. Ascertaining the differences between the prior art and the claims at issue.
3. Resolving the level of ordinary skill in the pertinent art.
4. Considering objective evidence present in the application indicating obviousness or nonobviousness.
This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention.
3. Claim(s) 7-10, and 14-20 is/are rejected under 35 U.S.C. 103 as being unpatentable over Merkx et al. (“Area-Selective Atomic Layer Deposition of TiN Using Aromatic Inhibitor Molecules for Metal/Dielectric Selectivity”) in view of Ko et al. (U.S. PGPUB No. 2023/0369039).
Regarding claims 7-10, and 14-20, Merkx teaches a process for selectively depositing a thin film (abstract) comprising: preparing a target surface comprising a first surface which is cobalt (Section 2.3 and Figure 4), and a second surface which is silica (Section 2.3 and Figure 4); forming an inhibitor layer by selective deposition on the metal surface of aniline
PNG
media_image1.png
98
80
media_image1.png
Greyscale
(abstract and Figure 1) at 250 ºC (Section 2.1); selectively forming a subsequent layer of ALD deposited TiN at 250 ºC (Section 2.1, and this selective deposition results in the thickness of the subsequent layer having a greater thickness than the layer deposited above the first surface) on the second surface by atomic layer deposition over the substrate including the inhibitor layer and second surface (abstract); and then removal of the inhibitor layer (Figure 1) by hydrogen plasma for 10 seconds (Figure 1 and Section 2.1). Merkx also teaches the second layer is positioned on both sides of the first layer and spaced apart from each other (Figures 1 and 4), and a physical vapor deposition step after removing the inhibitor layer (Section 2.3). Merkx fails to teach the inhibitor being a compound of Formula I or a compound selected from the group of claim 8
However, Ko teaches a similar process for selectively depositing a thin film (abstract and Figure 1A) using an inhibitor compound, such as 4-trifluoromethyl benzaldehyde or aniline (claim 3). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Merkx’s process by substituting 4-trifluoromethyl benzaldehyde for the aniline of Merkx’s process. One would have been motivated to make this substitution as one could have made this modification with a reasonable expectation of success (note the similarities between the processes and that Ko teaches that the inhibitor can be any selected from a group including aniline at claim 3, which is used by Merkx, and other aniline variants such as 4-(methythio)aniline), and the predictable result of providing a blocking layer for selective deposition of a subsequent layer.
4. Claim(s) 11-13 is/are rejected under 35 U.S.C. 103 as being unpatentable over Merkx in view of Ko as applied to claim 7 above, and further in view of Leoncini et al. (U.S. PGPUB No. 2022/0130660).
I. Regarding claims 11 and 12, Merkx in view of Ko make obvious claim 7, but fail to teach a pretreatment step as claimed in claims 11 and 12. However, Leoncini teaches a similar process for selectively depositing a thin film (abstract) comprising: preparing a target surface comprising a first surface (abstract), which is metal (claim 3), such as copper or cobalt (claim 3), and a second surface (abstract) which is a dielectric (claim 5), such as silica (claim 5); forming an inhibitor layer by selective deposition on the metal surface of an anchor reactant (claim 1) which is a 4-ethynylbenzene derivative
PNG
media_image2.png
82
146
media_image2.png
Greyscale
(claim 4) where A represents an anchor group for adhering to the metal surface (0026); selectively forming a subsequent layer, such as TiN (0028), on the second surface by atomic layer deposition over the substrate including the inhibitor layer and second surface (claim 14); and then removal of the inhibitor layer (claim 18), potentially by hydrogen plasma (0031). Leoncini also teaches pretreating the first metal surface by using a hydrogen plasma (0029). Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify Merkx in view of Ko’s process by including a hydrogen pretreatment step on the metal surface. One would have been motivated to make this modification as Leoncini teaches that the pretreatment cleans the substrate to form an optimal surface for the selective deposition process (0029).
II. Regarding claim 13, Merkx in view of Ko and further in view of Leoncini make obvious claim 11, but fail to teach the length of time the hydrogen plasma is conducted for. However, adjusting the amount of time will alter the efficiency of the process, the cleanliness of the resultant surface and the damage done to the substrate by the plasma. Therefore, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to choose the instantly claimed range through process optimization, since it has been held that where the general conditions of a claim are disclosed in the prior art, discovering the optimum or workable ranges involves only routine skill in the art. See In re Boesch, 205 USPQ 215 (CCPA 1980).
Conclusion
Claims 1-20 are pending.
Claims 1-20 are rejected.
Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to ROBERT S WALTERS JR whose telephone number is (571)270-5351. The examiner can normally be reached Monday-Friday 8-5.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Dah-Wei Yuan can be reached at 571-272-1295. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/ROBERT S WALTERS JR/
November 4, 2026Primary Examiner, Art Unit 1717